Dow Down0.22% Nasdaq Up0.14%

More On IMC.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Immuron Limited (IMC.AX)

-ASX
0.01 0.00(0.00%) Aug 22, 1:58AM EDT
ProfileGet Profile for:
Immuron Limited
1233 High Street
Suite 1
Armadale, VIC 3143
Australia - Map
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Website: http://www.immuron.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:8

Business Summary 

Immuron Limited, a biopharmaceutical company, is engaged in the research and development, and sale of polyclonal antibodies for the treatment and prevention of various diseases in Australia and internationally. The company’s platform technology enables the development of medicines that target a range of medical needs, including infectious diseases, immune mediated disorders, and cancers. It commercializes its platform derived products through a range of regulatory pathways, including prescription, medical foods, over-the-counter medicines, and dietary supplements. The company offers Travelan, a natural product for the prevention of Travellers’ Diarrhoea. It is also developing IMM 272, a bovine colostrum powder to prevent rotavirus diarrhea; IMM 124-E, a natural product for the treatment of fatty liver and non-alcoholic steatohepatitis/type 2 diabetes; IMM 529 for the treatment of clostridium difficile infection; IMM-363 to treat of side effects caused by chemotherapy or radiation; and IMM-160 to reduce tumour size and suppress liver cancer. Immuron Limited was founded in 1994 and is based in Armadale, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Immuron Limited

Key Executives 
 PayExercised
Mr. Amos Meltzer , 48
Chief Exec. Officer and VP of Bus. Devel.
228.00KN/A
Mr. Joseph M. Baini BSc, 48
External Advisor
192.00KN/A
Mr. Phillip Allen Hains CA, MBA, 51
Joint Chief Financial Officer and Joint Company Sec.
N/AN/A
Mr. Peter Vaughan ,
Joint Chief Financial Officer and Joint Company Sec.
N/AN/A
Dr. Grant Rawlin B Sc (Vet) (Hons) B VSc,
Chief Scientific Officer
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.